Site Map

Qsam doses first patient in Cyclosam clinical trial

Intelerad appoints new executives

Lower sales of COVID tests drag down Hologic Q2 revenues

inHeart enrolls European patients for AI heart model trial

Accuray sees Q3 revenues decreases, names new CEO

Lower breast cancer incidence in Asian women not necessarily good

Radiation doses in swallow studies remain high in the U.K.

CT patient positioning plays key role in radiation dose reduction

Page 1 of 1